Clinical Trials Browser

Phase 2 × CAG protocol × Clear all

NCT05918198 2023-11-21

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute